Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	177	193	491	-	-
Market Cap Growth	-47.76%	-60.71%	-	-	-
Enterprise Value	-24	-1	246	-8	-1
PE Ratio	-	-3.81	-17.97	-	-
PB Ratio	0.79	0.93	1.99	-	-
P/FCF Ratio	-2.36	-5.77	-18.05	-	-
P/OCF Ratio	-2.36	-5.85	-18.05	-	-
EV/EBITDA Ratio	1.50	0.02	-9.01	0.71	0.18
EV/EBIT Ratio	1.49	0.02	-9.01	0.70	0.18
EV/FCF Ratio	1.69	0.04	-9.05	1.74	0.27
Debt / Equity Ratio	0.02	0.02	-	-	-
Debt / EBITDA Ratio	-0.07	-0.08	-	-	-
Debt / FCF Ratio	-0.07	-0.12	-	-	-
Quick Ratio	29.29	17.79	66.48	5.30	2.14
Current Ratio	29.93	18.16	67.38	5.37	2.25
Return on Equity (ROE)	-24.80%	-22.70%	-25.70%	54.90%	-
Return on Assets (ROA)	-23.60%	-21.60%	-21.00%	-239.00%	-
Return on Capital (ROIC)	-29.15%	-25.56%	-11.09%	19.95%	52.54%
Earnings Yield	-31.98%	-26.25%	-5.56%	-	-
FCF Yield	-28.08%	-17.32%	-5.54%	-	-
Buyback Yield / Dilution	-13.52%	-299.61%	-1594.35%	-257.58%	-
Total Shareholder Return	-13.52%	-299.61%	-1594.35%	-257.58%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).